- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Jiangsu ShengDiYa Medicine Co., Ltd.
Total 1367 results
-
Jiangsu HengRui Medicine Co., Ltd.WithdrawnNon-Small-Cell Lung Cancer
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced Solid TumorsChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedBreast Cancer | Solid Tumor | Gastrointestinal CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Enrolling by invitationPsoriatic ArthritisChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHypercholesterolemia and HyperlipidemiaChina
-
Jiangsu HengRui Medicine Co., Ltd.Enrolling by invitation
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced Esophageal CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingRecurrent or Metastatic Cervical CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHealthy SubjectsChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingChemotherapy-Induced ThrombocytopeniaChina
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedAdvanced Hepatocellular Carcinoma (HCC)China
-
Jiangsu HengRui Medicine Co., Ltd.CompletedTreatment of Dry Eye Disease With Meibomian Gland DysfunctionChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedTriple Negative Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHealthy Adult Male VolunteersChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedSmall Cell Lung CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Enrolling by invitation
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Enrolling by invitation
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHealthy SubjectsChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Enrolling by invitation
-
Jiangsu HengRui Medicine Co., Ltd.CompletedLocal Anesthesia Assisted SedationChina
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.SuspendedNeoplasms by Histologic Type | Lymphoma | Hematologic Neoplasms | Advanced Cancer | Immunotherapy | Physiological Effects of DrugsChina
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedLung NeoplasmsChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingChemotherapy Effect | Lung Cancer Stage IV | PD-1 Antibody | Lung Cancer Squamous CellChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingProstate Cancer | Hormone-Dependent Prostate CancerChina, Czechia, Poland, Bulgaria
-
Jiangsu HengRui Medicine Co., Ltd.Enrolling by invitation